Literature DB >> 21947685

The spectrum of functional gastrointestinal disorders in a tertiary referral clinic in Ireland.

K Walsh1, S R McWilliams, M M Maher, E M Quigley.   

Abstract

BACKGROUND: The functional gastrointestinal disorders (FGIDs) are a heterogenous group of chronic conditions which cause troubling gastrointestinal symptoms. Though common and sometimes disabling, causing considerable social and economic burden, there is little recent literature on presentation or impact of FGIDs in Ireland. AIM: To describe the characteristics of patients with FGIDs at a tertiary referral clinic in Ireland.
METHODS: A retrospective review of those attending a university hospital gastroenterology clinic with a special interest in FGIDs between January 1999 and July 2008 was performed. Data were mined from electronic outpatient records and clinic letters.
RESULTS: A total of 1,909 patients were included. Of these patients, 41.2% (787 of 1,909) received a diagnosis of FGID. FGID patients were predominantly (70.14%) female and the average age at first presentation was 38.3 years. Of these, 76% (598 of 787) were referred from general practice; 35.8% (282 of 787) received onward referrals to other specialties. Nine hundred FGIDs were diagnosed. The most common FGID was irritable bowel syndrome (633 of 900, 70.3%). In the FGID group, 13.1% of patients (103 of 787) had more than one FGID diagnosis. Females received a definitive diagnosis of FGID faster than males; mean diagnostic latency: 5.3 versus 6.4 months (p < 0.05). Sixty-six percent (523 of 787) of FGID patients had non-gastrointestinal co-morbidities, with 315 (60.2%) of these having more than one co-morbidity. The burden of non-GI co-morbidity was significantly higher in patients with overlapping functional syndromes than in patients with single FGID (p < 0.05).
CONCLUSIONS: In Ireland, FGIDs are common, represent a significant burden for the health-care system and deserve greater recognition and further research attention.

Entities:  

Mesh:

Year:  2011        PMID: 21947685     DOI: 10.1007/s11845-011-0756-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  21 in total

1.  Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders.

Authors: 
Journal:  J Gastrointestin Liver Dis       Date:  2006-09       Impact factor: 2.008

Review 2.  Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors.

Authors:  Filippo Cremonini; Nicholas J Talley
Journal:  Gastroenterol Clin North Am       Date:  2005-06       Impact factor: 3.806

3.  Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.

Authors:  Paul Scully; Declan P McKernan; John Keohane; David Groeger; Fergus Shanahan; Timothy G Dinan; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2010-04-20       Impact factor: 10.864

4.  Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain.

Authors:  Rachel E Williams; Katherine E Hartmann; Robert S Sandler; William C Miller; Lucy A Savitz; John F Steege
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

Review 5.  Irritable bowel syndrome: a little understood organic bowel disease?

Authors:  Nicholas J Talley; Robin Spiller
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

6.  Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression.

Authors:  Daniel F Gros; Martin M Antony; Randi E McCabe; Richard P Swinson
Journal:  J Anxiety Disord       Date:  2008-08-27

7.  Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress.

Authors:  L S Savas; D L White; M Wieman; K Daci; S Fitzgerald; S Laday Smith; G Tan; D P Graham; J A Cully; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2008-09-09       Impact factor: 8.171

Review 8.  Functional gastrointestinal disorders as a public health problem.

Authors:  N J Talley
Journal:  Neurogastroenterol Motil       Date:  2008-05       Impact factor: 3.598

9.  Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress.

Authors:  Cristina Almansa; Enrique Rey; Raquel García Sánchez; Angel Alvarez Sánchez; Manuel Díaz-Rubio
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-13       Impact factor: 11.382

10.  Gynaecological consultation in patients with the irritable bowel syndrome.

Authors:  A Prior; P J Whorwell
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

View more
  5 in total

Review 1.  Bugs on the brain; brain in the gut--seeking explanations for common gastrointestinal symptoms.

Authors:  E M M Quigley
Journal:  Ir J Med Sci       Date:  2012-11-22       Impact factor: 1.568

2.  Constipation in Iran: SEPAHAN Systematic Review No. 5.

Authors:  Niloufar Iraji; Ammar Hassanzadeh Keshteli; Shirin Sadeghpour; Parnaz Daneshpajouhnejad; Mohammadreza Fazel; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03

3.  Transanal Irrigation for Refractory Chronic Idiopathic Constipation: Patients Perceive a Safe and Effective Therapy.

Authors:  Kevin J Etherson; Ian Minty; Iain M Bain; Jeremy Cundall; Yan Yiannakou
Journal:  Gastroenterol Res Pract       Date:  2017-01-01       Impact factor: 2.260

4.  Computed tomography assessment of intestinal gas volumes in functional gastrointestinal disorders.

Authors:  Sebastian R Mc Williams; Patrick D Mc Laughlin; Owen J O'Connor; Alan N Desmond; Aine Ní Laoíre; Fergus Shanahan; Eamonn Mm Quigley; Michael M Maher
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

5.  Patients with Multiple Functional Gastrointestinal Disorders (FGIDs) Show Increased Illness Severity: A Cross-Sectional Study in a Tertiary Care FGID Specialty Clinic.

Authors:  Sabrina Berens; Felicitas Engel; Annika Gauss; Jonas Tesarz; Wolfgang Herzog; Beate Niesler; Esther Stroe-Kunold; Rainer Schaefert
Journal:  Gastroenterol Res Pract       Date:  2020-01-28       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.